A0A0S2Z4Z8 (A0A0S2Z4Z8_HUMAN) Homo sapiens (Human)

Receptor-interacting serine-threonine kinase 2 isoform 1 UniProtKBInterProInteractive Modelling

540 aa; Sequence (Fasta) ; 1 identical sequence: Homo sapiens: O43353

Available Structures

31 Experimental Structures

DescriptionPDB IDOligo-stateRangeLigands
Structure of RIP2K dimer bound to the XIAP BIR2 domain
8aza
 Heteromer
O43353; P98170; 		8-314
1×ZN;
Assess
p75NTR DD:RIP2 CARD
2n83
 Heteromer
O43353; P08138; 		435-539
Assess
Crystal structure of 14-3-3 sigma in complex with RIPK2 phosphopeptide
7obs
 Heteromer
O43353; P31947; 		535-540
2×CA; 6×MG;
Assess
Crystal structure of 14-3-3 sigma in complex with RIPK2 phosphopeptide and stabilizer Fusicoccin-A
7obt
 Heteromer
O43353; P31947; 		536-540
2×FSC; 4×MG; 2×CL;
Assess
Structure of RIP2 CARD domain
5yrn
homo-12-mer434-516
Assess
Structure of RIP2 CARD filament
6ggs
homo-10-mer433-518
Assess
Structure of RIP2 CARD domain fused to crystallisable MBP tag
6gfj
homo-4-mer435-522
4×GLC;
Assess
Structure of the kinase domain of human RIPK2 in complex with the inhibitor CSLP3
6s1f
homo-2-mer5-316
2×KRE;
Assess
Structure of the kinase domain of human RIPK2 in complex with the inhibitor CSLP18
6fu5
homo-2-mer5-316
2×E7N;
Assess
The identification and pharmacological characterization of 6-(tert-butylsulfonyl)-N-(5-fluoro-1H-in…
5j79
homo-2-mer2-310
2×6GE; 5×SO4;
Assess
Structure of the kinase domain of human RIPK2 in complex with ponatinib
4c8b
homo-2-mer8-316
2×0LI; 1×EDO;
Assess
RIP2 Kinase Catalytic Domain (1 - 310)
5ar2
homo-2-mer4-310
1×CA;
Assess
The identification and pharmacological characterization of 6-(tert-butylsulfonyl)-N-(5-fluoro-1H-in…
5j7b
homo-2-mer4-310
2×6GD;
Assess
RIP2 Kinase Catalytic Domain complex with 2({4[(1,3benzothiazol5yl)amino]6(2methylpropane2sulfonyl)…
6rna
homo-2-mer4-310
2×KA2;
Assess
RIP2 Kinase Catalytic Domain (1 - 310) complex with Benzimidazole
5ar5
homo-2-mer4-310
1×CA; 2×IQ7;
Assess
RIP2 Kinase Catalytic Domain complex with 5amino1tertbutyl3(3methoxyphenyl)1H pyrazole4carboxamide.
6szj
homo-2-mer5-310
2×M5W; 1×CA;
Assess
RIP2 Kinase Catalytic Domain complex with N(4,5dimethyl1Hpyrazol3yl)7methoxy6(2methylpropane2sulfon…
6hmx
homo-2-mer5-310
2×GEZ;
Assess
RIP2 Kinase Catalytic Domain complex with 2(4[(1,3benzothiazol5yl)amino]6(2methylpropane2sulfonyl)q…
6rn8
homo-2-mer5-310
2×K9T; 1×CA;
Assess
RIP2 Kinase Catalytic Domain (1 - 310) complex with SB-203580
5ar4
homo-2-mer5-310
2×SB2;
Assess
Identification of potent and selective RIPK2 inhibitors for the treatment of inflammatory diseases.
5w5o
homo-2-mer5-310
2×9XA;
Assess
RIP2 Kinase Catalytic Domain complex with 5-Amino-1-Phenylpyrazole-4-Carboxamide.
6sze
homo-2-mer5-310
2×M2B; 1×CA;
Assess
RIP2 Kinase Catalytic Domain (1 - 310) complex with Biaryl Urea
5ar7
homo-2-mer6-310
2×SR8;
Assess
RIP2 Kinase Catalytic Domain (1 - 310) complex with AMP-PCP
5ar3
homo-2-mer6-310
2×ACP; 2×MG;
Assess
RIP2 Kinase Catalytic Domain (1 - 310) complex with Biphenylsulfonamide
5ar8
homo-2-mer8-310
2×XYW;
Assess
Identification of potent and selective RIPK2 inhibitors for the treatment of inflammatory diseases
5w5j
homo-2-mer9-311
2×9WS; 3×SO4;
Assess
Structure of RIP2K(L294F) with bound AMPPCP
5ng0
homo-2-mer5-300
2×ACP; 2×MG; 1×CO;
Assess
Structure of RIP2K(D146N) with bound Staurosporine
5ng2
homo-2-mer5-298
2×STU; 6×PO4;
Assess
Crystal structure of the kinase domain of human RIPK2 in complex with the activation loop targeting…
6es0
monomer5-316
1×BW8;
Assess
RIP2 kinase catalytic domain complex with (5S,6S,8R)-2-(benzo[d]thiazol-5-yl)-6-hydroxy-4,5,6,7,8,9…
6ul8
monomer5-310
1×Q9J;
Assess
Structure of inactive kinase RIP2K(K47R)
5ng3
monomer9-297
6×SO4;
Assess
Solution structure of RIP2 CARD
2n7z
monomer434-539
Assess

1 SWISS-MODEL model

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
6s1f.1.Ahomo-2-mer0.785-316
2×KRE;100.00
Assess